The SHI Group continues to lead leader in the synthesis of tracer RI for PET scans
PET scans demonstrate significant effects for the image diagnosis of tumors, cerebral infarctions and cardiovascular diseases. Tracer RIs, such as the 18F-FDG, which is used for identifying the position of cancer by accumulating at the cancer nidus, are essential for PET scans, which have been adopted by many medical institutions.
The medication synthesis systems for PET available from the SHI Group make it possible to synthesize tracer RIs in a safe and stable manner.
An in-house synthesis system is provided for tracer RIs, encompassing nuclear species manufacturing to the administration of medications.
The SHI Group is the only Japanese manufacturer delivering cyclotrons for PET and providing support for PET diagnostics in Japan, from development through to after sales service, backed by an infallible framework.
(A manufacturing location was established in Niihama City, in Ehime Prefecture, with service sites established at eight locations nationwide from Hokkaido to Kyushu in order to provide speedy service.)
Operation training given at the launch of a facility, as well as the dispatch of operators, are provided by the SHI Accelerator Service Ltd., (our wholly owned subsidiary).
|18F-FDG synthesis equipment
|This is equipment for preparing 18F-FDG radioactive medications for PET from nuclear species produced by a cyclotron|
|15O gas synthesis equipment
|This is equipment for preparing 15O gas radioactive medications for PET from nuclear species produced by a cyclotron|
|Q-200 automatic quality control equipment||This is equipment for remotely conducting quality verifications of 18F-FDG radioactive medications produced by 18F-FDG synthesis equipment|
|Medication administering equipment
|This is equipment for administering 18F-FDG radioactive medications to test subjects|